Premenstrual Dysphoric Disorder Clinical Trial
Official title:
Adapting and Piloting Acceptance and Commitment Therapy (ACT) for Severe Premenstrual Mood Symptoms: An Open-label Feasibility Study of ACT-PM
In the weeks prior to menstruation, many individuals experience mood and physical symptoms that negatively impact their quality of life and functioning. Approximately 5% of women and menstruating individuals have such severe symptoms that they meet criteria for Premenstrual Dysphoric Disorder (PMDD). Further, of those with underlying mood disorders (i.e., depression, bipolar disorder) about 60% have cyclical worsening of symptoms classified as premenstrual exacerbation (PME). Both PMDD and PME are associated with significant impairment, yet limited effective options exist to treat these conditions. In this project, the investigators will adapt and evaluate an Acceptance and Commitment Therapy (ACT) group for PMDD and PME, entitled ACT-Premenstrual (ACT-PM), delivered virtually to maximize accessibility. The investigators will examine whether ACT-PM is feasible to deliver and whether it is acceptable to group participants and those facilitating the group. The study will lay the groundwork for future research to determine if the group is effective. If effective, the intervention could be scaled up to improve quality of life and outcomes for individuals suffering from PMDD and PME.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03862469 -
Premenstrual Hormonal and Affective State Evaluation (PHASE) Project
|
N/A | |
| Active, not recruiting |
NCT00536198 -
Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder
|
N/A | |
| Completed |
NCT03449979 -
Single Session of tACS in a Depressive Episode
|
N/A | |
| Completed |
NCT00516113 -
A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria
|
Phase 4 | |
| Recruiting |
NCT05098574 -
Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder
|
Phase 2 | |
| Withdrawn |
NCT04123483 -
EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders
|
Phase 4 | |
| Completed |
NCT00518570 -
Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)
|
N/A | |
| Not yet recruiting |
NCT01217775 -
Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
|
Phase 3 | |
| Terminated |
NCT02362191 -
Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD
|
N/A | |
| Completed |
NCT00678574 -
The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder
|
Phase 4 | |
| Active, not recruiting |
NCT05327075 -
Premenstrual Dysphoric Disorder:Knowledge,Attitude and Practice Among Egyptian Females
|
||
| Not yet recruiting |
NCT02448836 -
Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD)
|
N/A | |
| Completed |
NCT01799733 -
Alternative Treatments for Premenstrual Dysphoric Disorder
|
N/A | |
| Completed |
NCT06227676 -
Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT02508103 -
Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study
|
Phase 2/Phase 3 | |
| Completed |
NCT00927095 -
Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)
|
Phase 4 | |
| Completed |
NCT00089414 -
Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
|
Phase 2 | |
| Completed |
NCT01875718 -
A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD)
|
Phase 1/Phase 2 | |
| Completed |
NCT06136104 -
The Effects of Mixhers HERTIME Supplements on Menstrual Symptoms
|
N/A | |
| Completed |
NCT01385709 -
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
|
N/A |